Form 8-K - Current report:
SEC Accession No. 0001193125-25-283182
Filing Date
2025-11-14
Accepted
2025-11-14 16:39:42
Documents
23
Period of Report
2025-11-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d876714d8k.htm   iXBRL 8-K 36604
2 EX-1.1 d876714dex11.htm EX-1.1 279699
3 EX-4.1 d876714dex41.htm EX-4.1 65139
4 EX-5.1 d876714dex51.htm EX-5.1 21296
5 EX-5.2 d876714dex52.htm EX-5.2 17244
6 EX-99.1 d876714dex991.htm EX-99.1 10957
11 GRAPHIC g876714g10a40.jpg GRAPHIC 3739
12 GRAPHIC g876714g1113115900114.jpg GRAPHIC 3626
13 GRAPHIC g876714g36g59.jpg GRAPHIC 1549
14 GRAPHIC g876714g68a77.jpg GRAPHIC 6465
15 GRAPHIC g876714g69i42.jpg GRAPHIC 11645
  Complete submission text file 0001193125-25-283182.txt   729397

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA engn-20251112.xsd EX-101.SCH 3521
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE engn-20251112_def.xml EX-101.DEF 14197
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE engn-20251112_lab.xml EX-101.LAB 23226
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE engn-20251112_pre.xml EX-101.PRE 15045
25 EXTRACTED XBRL INSTANCE DOCUMENT d876714d8k_htm.xml XML 5900
Mailing Address 4868 RUE LEVY, SUITE 220 SAINT-LAURENT A8 H4R 2P1
Business Address 4868 RUE LEVY, SUITE 220 SAINT-LAURENT A8 H4R 2P1 (514) 332-4888
enGene Holdings Inc. (Filer) CIK: 0001980845 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1031
Type: 8-K | Act: 34 | File No.: 001-41854 | Film No.: 251487451
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)